South America Blister Packaging Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

Blister packaging is the most widely used secondary packaging format in Latin American pharmaceutical manufacturing, encompassing cold-formed and thermoformed formats. The South America pharmaceutical blister segment is valued at roughly $1.105 billion in 2026, extending from a regional pharmaceutical packaging market estimated at over $10.5 billion in the same year. Growth is firmly anchored in Brazil, Argentina, Colombia, and Chile, which together account for the largest share of regional pharmaceutical output and demand.

• •The pharmaceutical blister packaging sub-market in Latin America reached approximately $1.03 billion in 2025 and is projected at a 7.3% CAGR.
• •The broader South American pharmaceutical packaging market was valued at $10,561.4 million in 2025 and is forecast to nearly triple by 2030.
• •Globally, the blister packaging market stands at roughly $23-25 billion, confirming that the Latin American region represents a growing but still modest share of a much larger market.

The primary engine of growth is the expansion of domestic pharmaceutical manufacturing across the region, as governments pursue healthcare sovereignty and cost-effective generic drug supply chains. Stricter regulatory mandates from regional health authorities, covering child-resistance, tamper-evidence, serialization, and track-and-trace compliance, are accelerating the shift toward high-integrity blister formats over loose-tablet or bottle-based alternatives.

• •Rising prevalence of chronic diseases, aging demographics, and expanded public health coverage are boosting unit-dose medicine consumption.
• •Government-backed generic drug programs across multiple South American countries are increasing the volume of products requiring standardized, regulatory-compliant blister packaging.
• •Strengthening anti-counterfeiting laws and serialization requirements are driving conversion from basic packaging formats toward advanced push-through and peelable blister systems.

Brazil dominates the South American blister packaging landscape by a wide margin, reflecting its position as the region's largest pharmaceutical manufacturing base. Argentina, Colombia, and Chile represent secondary demand hubs, with smaller but growing markets in Peru and Ecuador. Product segmentation is broadly split between cold-formed blister packs (using aluminum lidding) favored for moisture-sensitive drugs, and thermoformed plastic formats preferred for cost-sensitive generic products.

• •Brazil accounts for the largest share of regional blister demand, supported by a large domestic generic drug industry and national serialization mandates.
• •Secondary markets include Argentina and Colombia, where local pharmaceutical capacity expansion is increasingly served by regional rather than imported packaging.
• •Cold-form aluminum blisters and thermoformed PVC/PP/PET plastic blisters are the two dominant product formats, with material choice driven by product sensitivity and cost considerations.

Who are the notable companies in the industry?

The competitive structure of the Latin American pharmaceutical blister packaging market is moderately fragmented, featuring a mix of regional specialist converters serving the domestic pharmaceutical industry alongside larger integrated packaging groups with broader Latin American footprints. Capacity is concentrated in industrial corridors of Brazil, Central Mexico, and to a lesser extent Colombia, where proximity to major pharmaceutical manufacturing clusters is a key competitive advantage.

• •The market is best described as moderately fragmented, with a handful of larger integrated converters and a long tail of smaller specialty producers serving niche pharmaceutical and nutraceutical customers.
• •Many leading participants operate integrated supply chains covering the manufacture or sourcing of plastic films (PVC, PP, PET, and aluminum foil) through to printing, forming, and sealing of finished blister packs.
• •Primary feedstock routes rely on petrochemical-derived plastic resins (PVC, PP, PET) and aluminum foil, with significant dependence on imported polymer supply in smaller South American markets that lack domestic petrochemical capacity.

What are the recent trends and outlook?

The market is expected to sustain a strong growth trajectory through the early 2030s, underpinned by ongoing healthcare infrastructure investment and pharmaceutical localization policies. Material innovation is a key trend, with a gradual shift from traditional PVC toward recyclable and more sustainable substrate combinations driven by environmental regulations in Brazil and the European Union, which indirectly influences export-oriented South American manufacturers. Smart and interactive blister packaging incorporating digital tracking features is an emerging segment.

• •The pharmaceutical blister packaging segment is expected to reach nearly $1.7 billion by 2030 at current CAGR trajectories, reflecting continued above-market growth.
• •Environmental and regulatory pressure is accelerating development and adoption of PVC-free and mono-material blister structures that support recycling targets.
• •Digital integration, including QR codes, NFC tags, and serialization data embedded in blister lidding, is becoming a differentiator as regional governments enforce stricter anti-counterfeiting regimes.